SIDRANSKY DAVID — SEC insider filings

SEC reporting owner CIK 1277161. 18 insider filings on record with FilingPulse; latest filed 2026-11-09.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2020-10-28 to 2026-11-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Old Ayala, Inc (AYLA)Director48 legs · 250 sh · $3,700—5
Orgenesis Inc. (ORGS)Director34 legs · 180 sh · $1,072—2
CHAMPIONS ONCOLOGY, INC. (CSBR)Director10——16
Ayala Pharmaceuticals, Inc. (ADXS)Director1——3

Insider filings — SIDRANSKY DAVID

FiledFormIssuerReported transactionsSource
2026-11-094CHAMPIONS ONCOLOGY, INC. (CSBR)Grant/award (A): 31,216 (derivative) @ $4.76EDGAR
2025-11-074CHAMPIONS ONCOLOGY, INC. (CSBR)Grant/award (A): 21,216 (derivative) @ $6.80EDGAR
2024-11-184CHAMPIONS ONCOLOGY, INC. (CSBR)Grant/award (A): 21,880 (derivative) @ $4.64EDGAR
2023-12-214Orgenesis Inc. (ORGS)Grant/award (A): 20,450 (derivative) @ $0EDGAR
2023-11-074CHAMPIONS ONCOLOGY, INC. (CSBR)Grant/award (A): 15,495 (derivative) @ $5.51EDGAR
2023-08-174CHAMPIONS ONCOLOGY, INC. (CSBR)Grant/award (A): 11,480 (derivative) @ $7EDGAR
2023-01-234Ayala Pharmaceuticals, Inc. (ADXS)Grant/award (A): 46 · Grant/award (A): 2,342 (derivative) · Grant/award (A): 2,342 (derivative)EDGAR
2023-01-234Old Ayala, Inc (AYLA)Disposition to issuer (D): 250 · Disposition to issuer (D): 12,500 (derivative) · Disposition to issuer (D): 12,500 (derivative)EDGAR
2022-12-294Orgenesis Inc. (ORGS)Grant/award (A): 20,450 (derivative) @ $0EDGAR
2022-10-144CHAMPIONS ONCOLOGY, INC. (CSBR)Option exercise (M): 8,333 @ $3.21 · Tax withholding (F): 3,562 @ $7.51 · Option exercise (M): 8,333 (derivative) @ $0EDGAR
2022-06-154Ayala Pharmaceuticals, Inc. (AYLA)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2021-11-094CHAMPIONS ONCOLOGY, INC. (CSBR)Grant/award (A): 8,045 (derivative) @ $10.10EDGAR
2021-10-194CHAMPIONS ONCOLOGY, INC. (CSBR)Option exercise (M): 16,667 @ $1.59 · Tax withholding (F): 2,629 @ $10.08 · Grant/award (A): 16,667 (derivative) @ $0EDGAR
2021-06-144Ayala Pharmaceuticals, Inc. (AYLA)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2021-03-084Ayala Pharmaceuticals, Inc. (AYLA)Purchase (P): 200 @ $15.27 · Purchase (P): 25 @ $15.02 · Purchase (P): 1 @ $9.60 · Purchase (P): 4 @ $11.86 · Purchase (P): 5 @ $11.07 · Purchase (P): 10 @ $10.07 · +2 moreEDGAR
2021-01-114Orgenesis Inc. (ORGS)Purchase (P): 10 @ $5.42 · Purchase (P): 90 @ $5.90 · Purchase (P): 70 @ $5.96 · Purchase (P): 10 @ $6.98EDGAR
2020-12-104CHAMPIONS ONCOLOGY, INC. (CSBR)Grant/award (A): 8,333 (derivative) @ $11.96EDGAR
2020-10-284CHAMPIONS ONCOLOGY, INC. (CSBR)Option exercise (M): 16,667 @ $5.46 · Tax withholding (F): 10,100 @ $9.01 · Option exercise (M): 16,667 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-27 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1277161 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs